Your browser is no longer supported. Please, upgrade your browser.
SNY Sanofi weekly Stock Chart
SNY [NASD]
Sanofi
Index- P/E28.04 EPS (ttm)1.58 Insider Own16.40% Shs Outstand2.52B Perf Week2.02%
Market Cap111.72B Forward P/E12.56 EPS next Y3.54 Insider Trans0.00% Shs Float2.23B Perf Month3.93%
Income3.97B PEG3.59 EPS next Q0.98 Inst Own7.50% Short Float0.10% Perf Quarter0.75%
Sales40.66B P/S2.75 EPS this Y15.50% Inst Trans-4.41% Short Ratio1.69 Perf Half Y-2.20%
Book/sh24.99 P/B1.78 EPS next Y8.17% ROA- Target Price52.00 Perf Year1.51%
Cash/sh2.96 P/C14.98 EPS next 5Y7.80% ROE- 52W Range40.00 - 45.62 Perf YTD2.30%
Dividend1.74 P/FCF- EPS past 5Y4.80% ROI5.00% 52W High-2.65% Beta0.57
Dividend %3.92% Quick Ratio0.90 Sales past 5Y2.70% Gross Margin68.60% 52W Low11.02% ATR0.63
Employees104226 Current Ratio1.30 Sales Q/Q6.50% Oper. Margin- RSI (14)61.33 Volatility1.35% 1.07%
OptionableYes Debt/Eq0.47 EPS Q/Q-40.80% Profit Margin- Rel Volume1.21 Prev Close44.30
ShortableYes LT Debt/Eq0.39 EarningsOct 28 BMO Payout- Avg Volume1.36M Price44.41
Recom1.50 SMA202.01% SMA504.34% SMA2003.82% Volume1,655,800 Change0.25%
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Aug-30-17Upgrade HSBC Securities Reduce → Hold
May-11-17Downgrade Berenberg Buy → Hold
Apr-07-17Downgrade HSBC Securities Hold → Reduce
Apr-06-17Initiated Argus Buy $50
Mar-09-17Initiated Liberum Hold
Nov-07-16Initiated Goldman Neutral
Sep-23-16Initiated Piper Jaffray Neutral
Sep-15-16Resumed JP Morgan Underweight
Sep-17-19 10:27AM  Alnylam Begins Phase III Study on Onpattro for New Indication Zacks
08:38AM  Abbott Partners With Sanofi to Upgrade Diabetes Management Zacks
03:42AM  Factbox: Britain's insulin providers prepare for Brexit fallout Reuters
01:00AM  Happify Health and Sanofi Sign Global Agreement to Bring Prescription Digital Mental Health Therapeutics to Individuals with Multiple Sclerosis PR Newswire
Sep-16-19 01:39PM  Top Trending: Abbott and Sanofi team up to help diabetes patients, Boeings board expected to reconsider engineering Yahoo Finance Video
01:18PM  Aimmune's Peanut Allergy Drug Gets FDA Committee's Support Zacks
09:13AM  Abbott, Sanofi to help diabetes patients with technology team-up Yahoo Finance
07:00AM  Market Morning: Johnson Defies Benn, Saudi Oil Black Swan, Golden Toilet Heist Market Exclusive
Sep-13-19 09:12PM  Hagens Berman: National Class-Action Lawsuit Accuses Sanofi of Concealing Zantac Cancer Risk Business Wire
04:16PM  Popular Sanofi Heartburn Drug Could Contain Carcinogens, FDA Says Investor's Business Daily
10:20AM  CORRECTED-U.S. FDA flags probable cancer-causing impurity in common heartburn drugs Reuters
10:08AM  Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use Zacks
09:01AM  FDA Says Sanofi's Zantac Medication Has Impurity That Could Cause Cancer TheStreet.com
06:28AM  NewsBreak: Low Levels of Carcinogen Found in Heartburn Drug Zantac Investing.com
Sep-12-19 09:41AM  J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients Zacks
Sep-11-19 07:42PM  Woodlands-based pharma co. to receive $260M in drug dispute settlement American City Business Journals
05:47PM  East Bay company eyes first drug approval after decade-long journey American City Business Journals
03:50PM  Leaner Pfizer Positioned to Boost R&D Output GuruFocus.com
09:46AM  Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally Zacks
07:09AM  The Daily Biotech Pulse: Lexicon Snaps Sanofi Diabetes Partnership With $260M Settlement, Celyad Offering, Multiple Sclerosis Conference Gets Underway Benzinga
Sep-10-19 04:51PM  Sanofi to pay Lexicon $260 mln for terminated partnership Reuters
Sep-09-19 09:10AM  Should Value Investors Buy Sanofi (SNY) Stock? Zacks
Sep-06-19 09:14AM  UPDATE 1-Novo Nordisk to cut insulin prices in the U.S. Reuters
07:57AM  Novo Nordisk to cut insulin prices for some U.S. diabetics Reuters
Sep-05-19 12:52PM  Podcast: Why Big Pharma Is Betting on a New Biotech Therapy Barrons.com
11:12AM  Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class? Motley Fool
Sep-04-19 10:02AM  Biotech Stock Roundup: REGN Wins Against AMGN, VRTX to Acquire Semma & More Zacks
09:37AM  Novartis Inks Commercialization Deal for Tysabri Biosimilar Zacks
07:24AM  L'Oreal U.S.A. Inc. -- Moody's affirms L'Oréal S.A.'s Prime-1 rating, stable outlook Moody's
Sep-03-19 12:55PM  Here's How Emergent BioSolutions Procured a Higher Price Today Motley Fool
09:04AM  Sanofi Stock Is a Buy Because of Its Drug Pipeline, Analyst Says Barrons.com
03:11AM  What Kind Of Investor Owns Most Of Sanofi (EPA:SAN)? Simply Wall St.
Aug-30-19 10:26AM  Esperion's Bempedoic Acid Succeeds in Phase II Diabetes Study Zacks
08:04AM  Novartis' (NVS) MS Drug Achieves Goals in Late-Stage Studies Zacks
06:30AM  How To Trade Growth Stocks: The Easy Way To Check And Confirm Institutional Support Investor's Business Daily
02:17AM  UPDATE 2-Novartis takes aim at Roche's star MS drug Reuters
Aug-29-19 09:16AM  Regeneron-Sanofi Get Favorable Ruling Against Amgen in Court Zacks
07:38AM  The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings Benzinga
Aug-28-19 04:18PM  U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight Reuters
04:00PM  Biotech Stock On The Radar: MyoKardia Bets On Precision Medicine For Heart Health Benzinga
03:41PM  UPDATE 3-U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight Reuters
03:18PM  U.S. judge rules for Sanofi in Amgen patent fight Reuters
02:28PM  Emergent's Vaccine Portfolio Aids Growth Amid Competition Zacks
Aug-26-19 04:49PM  Inovio (INO) Down More Than 30% in 3 Months: Here's Why Zacks
11:05AM  Esperion's Drugs in Review Hold Potential, Funds a Concern Zacks
Aug-22-19 10:20AM  Pfizer's Xtandi Label Expansion Filing Gets Priority Review Zacks
09:10AM  Is Sanofi (SNY) a Great Value Stock Right Now? Zacks
Aug-21-19 06:00AM  Three Value Stocks for Global Gains MoneyShow
Aug-20-19 05:35PM  Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster Benzinga
05:14PM  Inovio Ends Enrollment in Anal Dysplasia Study on VGX-3100 Zacks
Aug-15-19 08:28AM  Regeneron Gets FDA Nod for Eylea Injection Prefilled Syringe Zacks
Aug-14-19 10:00AM  Should Value Investors Consider Sanofi (SNY) Stock Now? Zacks
02:54AM  Does Sanofi's (EPA:SAN) CEO Pay Matter? Simply Wall St.
Aug-12-19 09:30AM  J&J's Tuberculosis Drug Gets FDA Nod for Adolescent Patients Zacks
02:26AM  No-deal Brexit could deepen Europe's shortage of medicines - experts Reuters
Aug-09-19 11:16AM  Inovio (INO) Q2 Earnings & Revenues Fall Shy of Estimates Zacks
09:50AM  Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Zacks
Aug-08-19 01:40PM  MyoKardia, Inc. (MYOK) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 03:26PM  3 Dividend Stocks That Pay You More Than Pepsi Does Motley Fool
08:13AM  Alnylam's (ALNY) Q2 Earnings and Revenues Miss Estimates Zacks
Aug-06-19 03:00PM  Regeneron Pharmaceuticals Reports Marked Improvement in Q2 Motley Fool
01:09PM  Regeneron (REGN) Q2 Earnings Top Estimates, Eylea Sales Solid Zacks
10:45AM  BioMarin's Roller Coaster Continues Motley Fool
09:30AM  SNY vs. PFE: Which Stock Is the Better Value Option? Zacks
09:10AM  Are Investors Undervaluing Sanofi (SNY) Right Now? Zacks
08:24AM  Regeneron stock up 2.2% after earnings beat MarketWatch
07:22AM  The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering Benzinga
01:40AM  UPDATE 1-EU approves Sanofi, Regeneron's Dupixent for adolescent eczema cases Reuters
01:15AM  EU regulators approve Sanofi, Regeneron's Dupixent for adolescent cases Reuters
Aug-05-19 05:59PM  Sanofi (SNY) Q2 2019 Earnings Call Transcript Motley Fool
Aug-02-19 10:52AM  Emergent (EBS) Earnings Miss in Q2, Revenues Beat Estimates Zacks
10:52AM  BioMarin (BMRN) Shares Down on Q1 Earnings & Sales Miss Zacks
09:54AM  Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger Zacks
Jul-30-19 09:49AM  Company News For Jul 30, 2019 Zacks
Jul-29-19 12:14PM  Here's Why Lexicon Pharmaceuticals Is Collapsing Today Motley Fool
10:41AM  Companies to Watch: mixed quarter at Sanofi, Starbucks downgraded, concerns for PayPal Yahoo Finance
10:38AM  Sanofi (SNY) Q2 Earnings Top, Dupixent Shines, EPS View Up Zacks
10:17AM  Companies to Watch: mixed quarter at Sanofi, Starbucks downgraded, concerns for PayPal Yahoo Finance Video
09:37AM  Sanofi Trades Higher On Q2 Earnings Beat Benzinga
08:53AM  Lexicon's stock loses more than half its value after Sanofi's notice to end alliance MarketWatch
08:00AM  Sanofi delivered solid growth in Q2 2019 PR Newswire
04:46AM  UPDATE 2-Europe stocks inch higher on UK merger action Reuters
02:18AM  UPDATE 1-Sanofi raises outlook after strong Q2 numbers Reuters
02:16AM  Sanofi raises outlook after strong second quarter Reuters
Jul-28-19 06:02PM  Sanofi's Earnings: A Preview Benzinga
Jul-27-19 05:05AM  Sanofi ends partnership with Lexicon to develop add-on pill for diabetes Reuters
Jul-26-19 05:58PM  UPDATE 1-Sanofi ends partnership with Lexicon to develop add-on pill for diabetes Reuters
05:05PM  Sanofi ends partnership with Lexicon to develop diabetes drug Reuters
Jul-25-19 06:52PM  Buy Merck & Co (MRK) Stock Ahead of Q2 Earnings Report? Zacks
10:26AM  AstraZeneca (AZN) Q2 Earnings Top, '19 Product Sales View Up Zacks
Jul-24-19 01:54PM  What to Expect from Sanofi's (SNY) Q2 Earnings (Revised) Zacks
12:13PM  What to Expect from Sanofi's (SNY) Q2 Earnings Zacks
09:44AM  Large-Cap Pharmaceuticals Industry Near-Term Outlook Bright Zacks
Jul-23-19 08:00AM  Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose GlobeNewswire
07:26AM  The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation Benzinga
01:15AM  Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu Reuters
Jul-19-19 09:40AM  How Does Sanofi (EPA:SAN) Fare As A Dividend Stock? Simply Wall St.
Jul-18-19 10:10AM  New Strong Buy Stocks for July 18th Zacks
Jul-17-19 11:20AM  Inovio (INO) Ends Some Early-Stage R&D Programs, Cuts Jobs Zacks
10:24AM  Merck's Antibiotic Recarbrio Gets FDA Nod for Infections Zacks
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia in adults and children; and Cablivi to treat acquired thrombotic thrombocytopenic purpura in adults. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. The company has an alliance with Verily Life Sciences LLC. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerSep 10Sale281.15172,90448,611,80420,550,813Sep 12 05:00 PM
Sanofi10% OwnerJul 22Buy16.0093,7501,500,000558,035Jul 23 11:39 AM
Sanofi10% OwnerMar 08Sale412.17131,11554,041,31620,723,717Mar 12 08:19 PM